Drug Pipeline

RP-6306 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05601440 Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2… Breast Cancer Recruiting
Phase 1
NCT04855656 Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With… Advanced Solid Tumor Recruiting
NCT06107868 Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine… Recurrent Ovarian Cancer Active, Not Recruiting
Sponsors Running RP-6306 Trials
Debiopharm International SA (1) Canadian Cancer Trials Group (1) University Health Network, Toronto (1)
Disease Areas
Breast Cancer (1) Ovarian Cancer (1) Endometrial Cancer (1)
Get alerts when RP-6306 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free